'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 66, Issue 11, Pages 2615-2623
Publisher
Oxford University Press (OUP)
Online
2011-09-03
DOI
10.1093/jac/dkr354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure
- (2011) Jonathan Z. Li JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
- (2011) Linda Wittkop et al. LANCET INFECTIOUS DISEASES
- Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy
- (2010) Derrick D Goodman et al. AIDS
- Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution
- (2010) J. A. Johnson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients
- (2010) Elias K. Halvas et al. JOURNAL OF INFECTIOUS DISEASES
- Pre‐existing Minority Drug‐Resistant HIV‐1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure
- (2010) Roger Paredes et al. JOURNAL OF INFECTIOUS DISEASES
- Minority Variants of Drug‐Resistant HIV
- (2010) Sara Gianella et al. JOURNAL OF INFECTIOUS DISEASES
- Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy
- (2009) Olivia Peuchant et al. AIDS
- Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors
- (2009) Vici Varghese et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe
- (2009) Jurgen Vercauteren et al. JOURNAL OF INFECTIOUS DISEASES
- Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes
- (2009) Birgitte B. Simen et al. JOURNAL OF INFECTIOUS DISEASES
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
- (2009) Diane E. Bennett et al. PLoS One
- Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
- (2008) Martin S. Hirsch et al. CLINICAL INFECTIOUS DISEASES
- Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients
- (2008) Karin J. Metzner et al. CLINICAL INFECTIOUS DISEASES
- Preexisting Resistance to Nonnucleoside Reverse‐Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz‐Based Regimen in Treatment‐Naive HIV‐1–Infected Subjects
- (2008) Daniel R. Kuritzkes et al. JOURNAL OF INFECTIOUS DISEASES
- Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy
- (2008) Jeffrey A Johnson et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now